Legis Daily

The Insulin Cost Reduction Act

USA117th CongressHR-5623| House 
| Updated: 10/20/2021
Glenn Grothman

Glenn Grothman

Republican Representative

Wisconsin

Cosponsors (2)
Rick W. Allen (Republican)Chris Jacobs (Republican)

Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
The Insulin Cost Reduction Act This bill prohibits the negotiation of price concessions between insulin manufacturers and prescription drug plans under the Medicare prescription drug benefit unless the price concessions are either provided at the point of sale to beneficiaries or are reflected in cost-sharing requirements.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Oct 19, 2021
Introduced in House
Oct 19, 2021
Referred to the Subcommittee on Health.
Oct 19, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 20, 2021
Referred to the Subcommittee on Health.
  • October 19, 2021
    Introduced in House
  • October 19, 2021
    Referred to the Subcommittee on Health.
  • October 19, 2021
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • October 20, 2021
    Referred to the Subcommittee on Health.

Health

The Insulin Cost Reduction Act

USA117th CongressHR-5623| House 
| Updated: 10/20/2021
The Insulin Cost Reduction Act This bill prohibits the negotiation of price concessions between insulin manufacturers and prescription drug plans under the Medicare prescription drug benefit unless the price concessions are either provided at the point of sale to beneficiaries or are reflected in cost-sharing requirements.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Oct 19, 2021
Introduced in House
Oct 19, 2021
Referred to the Subcommittee on Health.
Oct 19, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 20, 2021
Referred to the Subcommittee on Health.
  • October 19, 2021
    Introduced in House
  • October 19, 2021
    Referred to the Subcommittee on Health.
  • October 19, 2021
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • October 20, 2021
    Referred to the Subcommittee on Health.
Glenn Grothman

Glenn Grothman

Republican Representative

Wisconsin

Cosponsors (2)
Rick W. Allen (Republican)Chris Jacobs (Republican)

Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted